Related Experiment Video
Updated: May 29, 2026

A Protocol to Characterize the Morphological Changes of Clostridium difficile in Response to Antibiotic Treatment
Published on: May 25, 2017
Antimicrobial use and risk for recurrent Clostridium difficile infection.
Dimitri M Drekonja1, William H Amundson, Douglas D Decarolis
1Minneapolis Veterans Affairs Health Care System, Minneapolis, Mn, USA. drek0002@umn.edu
Using antibiotics after Clostridium difficile infection (CDI) treatment is common and increases the risk of recurrence. Clinicians should carefully consider the necessity of non-CDI antibiotics following CDI to mitigate this risk.
Area of Science:
- Infectious Diseases
- Microbiology
- Clinical Medicine
Background:
- Antimicrobial use during and after Clostridium difficile infection (CDI) is discouraged but not well-quantified.
- The impact of non-CDI antimicrobial therapy on CDI recurrence remains unclear.
Purpose of the Study:
- To determine the frequency of non-CDI antimicrobial use during and after CDI treatment.
- To assess the association between non-CDI antimicrobial use and recurrent CDI.
Main Methods:
- Retrospective review of 246 Clostridium difficile infection cases at a Veterans Affairs medical center (2004-2006).
- Outcomes assessed included non-CDI antimicrobial use during and within 30 days post-treatment, and CDI recurrence.
Main Results:
- 57% of patients received non-CDI antimicrobials; 33% received them after CDI treatment.
- Non-CDI antimicrobial therapy after CDI treatment was significantly associated with a 3-fold increase in recurrent CDI (OR 3.02; 95% CI, 1.66-5.52).
- Antimicrobial use during CDI treatment did not show an association with recurrence.
Conclusions:
- Post-CDI non-CDI antimicrobial therapy is frequent and significantly elevates the risk of disease recurrence.
- The increased risk of recurrence associated with antimicrobial exposure warrants careful consideration when prescribing non-CDI antibiotics after CDI.
Related Concept Videos
Clinical Significance of Antibiotic Resistance
Microbiota Modulation by Antibiotics
Factors Affecting the Risk of Infection
The integrity and count of the white blood cells help the body resist pathogens and fight infection. When impaired, it reduces the body's resistance to pathogens. The acidic pH levels of the gastrointestinal, genitourinary tracts, and skin create...
Healthcare Associated Infections II: Preventive Measures
The best practices for preventing healthcare-associated infections include hand hygiene, patient risk...
Dysbiosis of the Gut Microbiota
Urinary Tract Infection III: Diagnostic Studies and Interprofessional Care
